Abstract 518P
Background
Artificial Intelligence (AI) holds the promise to transform medicine during diagnosis, management and therapy of diseases. The AICCELERATE project will introduce an operational approach to develop AI-enabled digital solutions to improve medical processes by creating a digital twin. In our study, we performed the first pilot application of the AICCELERATE project at Bambino Gesù Children’s Hospital in Rome (OPBG). The aim of our study is to design a supervised machine learning (ML) model to predict time to surgery and time to diagnosis based (outputs) on time from admission to first consultation and imaging (inputs) in newly diagnosed pediatric patients.
Methods
We included pediatric patients with new diagnoses of brain tumors, treated in OPBG from December 2017 to December 2022. We collected from EHR the following data: age and sex, start and end date of the first admission, department of hospitalization, consultations and radiological imaging date, diagnosis, and surgery date.
Results
We included 48 patients with a pediatric brain tumor, with a mean age of 8.6 years. We used a multiple linear regression model, which does not require large datasets such as more complex models. Our analysis showed that delayed consulting and imaging led to a delayed diagnosis, with the consulting presenting a higher importance than the imaging. This result was validated by the model’s estimated regressors coefficients, with the consulting factor being assigned a larger weight β_C=1.81 than the imaging factor β_I=-0.33. Similarly, we observed that delayed consulting and imaging led to a delayed surgery, estimating a higher coefficient for the consulting β_C=0.71 than the one estimated for the imaging β_I=-0.06. While the ML model achieved a reasonable performance in both frameworks, the time to surgery was predicted with a lower MAE 4.45±0.87 compared to the diagnosis MAE of 6.74±0.95.
Conclusions
This preliminary study conducted in a small number of patients, suggests that decreasing time to consultation can shorten time to surgery in children with brain cancer. As the AICCELERATE is ongoing, more accurate models will be developed and will help to better understand how to optimize the journey of children with brain cancer.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
581P - The effect of exercise intervention on defecation related symptoms of colorectal cancer patients a randomized controlled trial
Presenter: Justin Jeon
Session: Poster session 10
582P - High accuracy of a blood-based multimodal ctDNA test to detect advanced neoplasms in a FIT-positive screening population
Presenter: Joana Vidal Barrull
Session: Poster session 10
583P - A rapid blood test for the earlier detection of colorectal cancer
Presenter: Jennifer Nobes
Session: Poster session 10
584P - Two-year update of the prospective evaluation of ColonAiQ (PreC) study
Presenter: Yanbing Ding
Session: Poster session 10
585P - Fragmentomics early detection assay leading to potential clinical benefits in colorectal cancer
Presenter: Yuepeng Cao
Session: Poster session 10
586P - Minimal residual disease (MRD) detection using a tumour naïve circulating tumour DNA (ctDNA) assay in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial
Presenter: Daphne Day
Session: Poster session 10
588P - PLCRC-PROVENC3 study: Prognostic value of post-surgery liquid biopsy circulating tumor DNA in stage III colon cancer patients
Presenter: Carmen Rubio-Alarcón
Session: Poster session 10
589P - Impact of landmark point selection on molecular residual disease detection in stage I-IV resectable colorectal cancer
Presenter: Di Cao
Session: Poster session 10
590P - Assessment of circulating tumor (ct)DNA in patients (pts) with locally advanced rectal cancer (LARC) pts treated with neoadjuvant therapy (NAT)
Presenter: Chiara Molinari
Session: Poster session 10